Type 2 diabetic patients and their offspring show altered parameters of iron status, oxidative stress and genes related to mitochondrial activity

BioMetals

Volumn 25, Issue 4, 2012, Pages 725-735

  Blanc, Solange Le ^a   Villarroel, Pia ^a   Candia, Valeria ^a   Gavilán, Natalia ^b   Soto, Néstor ^c   Pérez Bravo, Francisco ^d   Arredondo, Miguel ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b Consultorio Eduardo Frei Montalva ^*  (Chile)

^c HOSPITAL SAN BORJA ARRIARÁN   (Chile)

^d UNIVERSITY OF CHILE   (Chile)

Author keywords

Bcl2 Bax ratio; Diabetes mellitus; Iron; Mitofusin; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; FERRITIN; GLUCOSE; GLUTATHIONE; HEME OXYGENASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; IRON; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN BAX; PROTEIN BCL 2; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSFERRIN RECEPTOR;

ADULT; APOPTOSIS; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; IRON BLOOD LEVEL; IRON STORAGE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PROGENY; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADULT; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; FEMALE; FERRITINS; GLUTATHIONE; HEME OXYGENASE (DECYCLIZING); HUMANS; INSULIN; IRON; LIPIDS; MALE; MIDDLE AGED; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; OXIDATIVE STRESS; RECEPTORS, TRANSFERRIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAMIN E;

EID: 84864917790     PISSN: 09660844     EISSN: 15728773     Source Type: Journal    
DOI: 10.1007/s10534-012-9540-z     Document Type: Article

References (50)

1. Acosta AM, Escalona M, Maiz A, Pollak F, Leighton F (2002) Determinación del índice de resistencia insulínica mediante homa en una población de la región metropolitana de Chile. Rev Med Chile 130:1227-1231
2. Alemany M (2011) Utilization of dietary glucose in the metabolic syndrome. Nutr Metab 8:74
3. Arredondo M, Jorquera D, Carrasco E, Albala C, Hertrampf E (2007) Microsatellite polymorphism in the heme oxygenase- 1 gene promoter is associated with iron status in persons with type 2 diabetes mellitus. Am J Clin Nutr 86:1347-1353
4. Bach D, Naon D, Pich S, Soriano FX, Vega N, Rieusset J, Laville M, Guillet C, Boirie Y, Wallberg-Henriksson H, Manco M, Calvani M, Castagneto M, Palacin M, Mingrone G, Zierath JR, Vidal H, Zorzano A (2005) Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes 4:2685-2693
5. Bacha F, Lee S, Gungor N, Arslanian SA (2010) From prediabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation. Diabetes Care 33:2225-2231
6. Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, Iannelli A, Staccini-Myx A, Casanoca D, Ben Amor I, Saint-Paul MC, Huet PM, Sadoul JL, Gugenheim J, Kaila S, Tran A, Marchand-Brustel YL (2006) Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 131:788-796
7. Bonomini F, Tengattini S, Fabiano A, Bianchi R, Rezzani R (2008) Atherosclerosis and oxidative stress. Histol Histopathol 23:381-390
8. Callahan ST, Mansfield MJ (2000) Type 2 diabetes mellitus in adolescents. Curr Opin Pediatr 12:310-315
9. Celis-Morales CA, Perez-Bravo F, Ibañes L, Sanzana R, Hormazabal E, Ulloa N, Calvo C, Bailey ME, Gill JM (2011) Insulin resistance in Chileans of European and indigenous descent: evidence for an ethnicity 9 environment interaction. PLoS ONE 6:e24690
10. Cepeda-Lopez AC, Aeberli I, Zimmermann MB (2010) Does obesity increase risk for iron deficiency? A review of the literature and the potential mechanisms. Int J Vitam Nutr Res 80:263-270
11. Chang JC, Kou SJ, Lin WT, Liu CS (2010) Regulatory role of mitochondria in oxidative stress and atherosclerosis. World J Cardiol 2:150-159
12. Chen KH, Guo X, Ma D, Guo Y, Li Q, Yang D, Li P, Qiu X, Wen S, Xiao RP, Tang J (2004) Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol 6:872-883
13. Cleland MM, Norris KL, Karbowski M, Wang C, Suen DF, Jiao S, George NM, Luo X, Li Z, Youle RJ (2011) Bcl-2 family interaction with the mitochondrial morphogenesis machinery. Cell Death Differ 18:235-247
14. Cook J, Flowers CH, Skikne BS (2003) The quantitative assessment of body iron. Blood 101:3359-3363
15. Crist BL, Alekel DL, Ritland LM, Hanson LN, Genschel U, ReddyMB(2009) Association of oxidative stress, iron, and centralized fat mass in healthy postmenopausal women. J Womens Health (Larchmt) 18:795-801
16. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111:1448-1454
17. Fernandez-Real JM, Lopez-Bermejo A, RicartW(2002) Crosstalk between iron metabolism and diabetes. Diabetes 51:2348-2354
18. Guo X, Chen KH, Guo Y, Liao H, Tang J, Xiao RP (2007) Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway. Circ Res 101:1113-1122
19. Halpern A, Mancini MC, Magalhães ME, Fisberg M, Radominski R, Bertolami MC, Bertolami A, de Melo ME, Zanella MT, Queiroz MS, Nery M (2010) Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment. Diabetol Metab Syndr 2:55-75
20. Hoogeveen RC, Ballantyne CM, Bang H, Heiss G, Duncan BB, Folsom AR, Pankow JS (2007) Circulating oxidised lowdensity lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the atherosclerosis risk in Communities Study. Diabetologia 50:36-42
21. Imamura M, Maeda S (2011) Genetics of type 2 diabetes: the GWAS era and future perspectives [Review]. Endocr J 58:723-739
22. Jiamsripong P, Mookadam M, Honda T, Khandheria BK, Mookadam F (2008) The metabolic syndrome and cardiovascular disease: part I. Prev Cardiol 11:155-161
23. Jin Y, Zheng S, Pu Y, Shu L, Sun L, Liu W, Fu Z (2011) Cypermethrin has the potential to induce hepatic oxidative stress, DNA damage and apoptosis in adult zebrafish (Danio rerio). Chemosphere 82:398-404
24. Johansen JS, Harris AK, Rychly DJ, Ergul A (2005) Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice [Review]. Cardiovasc Diabetol 4:5
25. Kalra N, Roy P, Prasad S, Shukla Y (2008) Resveratrol induces apoptosis involving mitochondrial pathways in mouse skin tumorigenesis. Life Sci 82:348-358
26. Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ (2003) Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 23:434-439
27. Khera T, Martin J, Riley S, Steadman R, Phillips AO (2006) Glucose enhances mesangial cell apoptosis. Lab Invest 86:566-577
28. Loboda A, Jazwa A, Grochot A, Rutkowski AJ, Cisowski J, Agarwal A, Jozkowicz A, Dulak J (2008) Heme oxygenase- 1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 10: 1767-1812
29. Marcovecchio M, Mohn A, Chiarelli F (2005) Type 2 diabetes mellitus in children and adolescents. J Endocrinol Invest 28:853-863
30. Mendiburo MJ, Le Blanc S, Espinoza A, Pizarro F, Arredondo M (2011) Transepithelial heme-iron transport: effect of heme oxygenase overexpression. Eur J Nutr 50(5):363-371
31. Merkel PA, Simonson DC, Amiel SA, Plewe G, Sherwin RS, Pearson HA et al (1988) Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. N Engl J Med 318:809-814
32. Metukuri MR, Reddy CM, Reddy PR, Reddanna P (2010) Bacterial LPS-mediated acute inflammation-induced spermatogenic failure in rats: role of stress response proteins and mitochondrial dysfunction. Inflammation 33: 235-243
33. Mojiminiyi OA, Marouf R, Abdella NA (2008) Body iron stores in relation to the metabolic syndrome, glycemic control and complications in female patients with type 2 diabetes. Nutr Metab Cardiovasc Dis 18:559-566
34. Muñoz C, López M, Olivares M, Pizarro F, Arredondo M, Araya M(2005) Differential response of interleukin-2 production to chronic copper supplementation in healthy humans. Eur Cytokine Netw 16:261-265
35. Niederau C, Berger M, Stremmel W, Starke A, Strohmeyer G, Ebert R et al (1984) Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia 26:441-444
36. NIH Publications (2005) National Cholesterol education Program. Detection, evaluation and treatment of high blood colesterol in adults (adult treatment panel III). No 02-5215
37. Ong SB, Hausenloy DJ (2010) Mitochondrial morphology and cardiovascular disease. Cardiovasc Res 88:16-29
38. Praveen EP, Kulshreshtha B, Khurana ML, Sahoo JP, Gupta N, Kumar G, Dwivedi SN, Ammini AC (2010) Obesity and metabolic abnormalities in offspring of subjects with diabetes mellitus. Diabetes Technol Ther 12:723-730
39. Reusens B, Theys N, Remacle C (2011) Alteration of mitochondrial function in adult rat offspring of malnourished dams. World J Diabetes 2:149-157
40. Rocha M, Apostolova N, Hernandez-Mijares A, Herance R, Victor VM (2010) Oxidative stress and endothelial dysfunction in cardiovascular disease: mitochondria-targeted therapeutics. Curr Med Chem 17:3827-3841
41. Sheftel AD, Kim SF, Ponka P (2007) Non-heme induction of heme oxygenase-1 does not alter cellular iron metabolism. J Biol Chem 282:10480-10486
42. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924
43. Sumida Y, Yoshikawa T, Okanoue T (2009) Role of hepatic iron in non-alcoholic steatohepatitis. Hepatol Res 39:213-222
44. Sun L, FrancoOH, Hu FB,Cai L, Yu Z, Li H, Ye X, Qi Q,Wang J, Pan A, Liu Y, Lin X (2008) Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly Chinese. J Clin Endocrinol Metab 93:4690-4696
45. Wang X (2001) The expanding role of mitochondria in apoptosis. Genes Dev 15:2922-2933
46. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:727-730
47. World Healths Organization (WHO) and Centers for Disease Control and Prevention (2007) Assessing the iron status of populations, 2nd edn. Geneva, 6-8 April 2004. ISBN 9789241596107 (electronic version)
48. Zhai L, Ballinger SW, Messina JL (2011) Role of reactive oxygen species in injury-induced insulin resistance. Mol Endocrinol 25:492-502
49. Zheng M, Xiao RP (2010) Role of mitofusin 2 in cardiovascular oxidative injury. J Mol Med 88:987-991
50. Zorzano A, Liesa M, Palacín M (2009) Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes. Int J Biochem Cell Biol 41:1846-1854